Evidence map›Paper›PMID 24342130›Full record

ArticleProstaglandins, leukotrienes, and essential fatty acids2014

Fish oil improves motor function, limits blood-brain barrier disruption, and reduces Mmp9 gene expression in a rat model of juvenile traumatic brain injury.

K L Russell, N E J Berman, P R A Gregg, B Levant

Open access · bronzeAbstract read
In one paragraph

Article in Prostaglandins, leukotrienes, and essential fatty acids, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

K L RussellDepartment of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160 USA. Electronic address: kristinlrussell@gmail.com.
N E J BermanDepartment of Anatomy & Cell Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA. Electronic address: nberman@kumc.edu.
P R A GreggDepartment of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160 USA. Electronic address: pragregg@gmail.com.
B LevantDepartment of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160 USA. Electronic address: blevant@kumc.edu.
University of Kansas Medical Center · US

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SUSAN J. BROWN · 2012 to 2026
$63.0M
UNDERSTANDING THE ROLE OF SMALL RNAS IN ARABIDOPSIS POLLEN DEVELOPMENTP20RR016475 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ACKLEY, BRIAN DOUGLAS · 2001 to 2011
$38.1M
Research Design and Analysis Core (RDAC)P30HD002528 · NICHD · UNIVERSITY OF KANSAS LAWRENCE · PI FOWLER, STEPHEN CLETIUS · 1985 to 2015
$22.1M
TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGYT32ES007079 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI HAGENBUCH, BRUNO · 1985 to 2015
$4.1M
Kansas University Training Program in Neurological and Rehabilitation SciencesT32HD057850 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Jacob J. Sosnoff · 2009 to 2026
$3.4M
NEURAL BASES OF MOTOR DYSFUNCTION AND REHABILITATIONT32HD007523 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI NUDO, RANDOLPH J · 2000 to 2004
$620k
N-3 Fatty Acids and Outcomes in Pediatric Traumatic Brain InjuryR03HD059939 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI LEVANT, BETH · 2009 to 2010
$149k
NCRR NIH HHS P20 RR016475NCRR NIH HHS P20RR016475NICHD NIH HHS P30 HD002528NICHD NIH HHS P30HD02528NICHD NIH HHS R03 HD059939NICHD NIH HHS R03HD059939NICHD NIH HHS T32 HD007523NICHD NIH HHS T32HD007523NICHD NIH HHS T32 HD057850NIEHS NIH HHS T32 ES007079NIEHS NIH HHS T32ES007079NIGMS NIH HHS P20 GM103418
6 · The paper itself

Abstract

The effects of an oral fish oil treatment regimen on sensorimotor, blood-brain barrier, and biochemical outcomes of traumatic brain injury (TBI) were investigated in a juvenile rat model. Seventeen-day old Long-Evans rats were given a 15mL/kg fish oil (2.01g/kg EPA, 1.34g/kg DHA) or soybean oil dose via oral gavage 30min prior to being subjected to a controlled cortical impact injury or sham surgery, followed by daily doses for seven days. Fish oil treatment resulted in less severe hindlimb deficits after TBI as assessed with the beam walk test, decreased cerebral IgG infiltration, and decreased TBI-induced expression of the Mmp9 gene one day after injury. These results indicate that fish oil improved functional outcome after TBI resulting, at least in part from decreased disruption of the blood-brain barrier through a mechanism that includes attenuation of TBI-induced expression of Mmp9.

Indexed as

WalkingAnimalsBlood-Brain BarrierBrain InjuriesFish OilsGene Expression Regulation, EnzymologicMatrix Metalloproteinase 9RatsRats, Long-EvansFish OilsMatrix Metalloproteinase 9Mmp9 protein, ratBlood–brain barrierFish oilJuvenileMatrix metalloproteinase 9RatTraumatic brain injury

Identifiers

PMID24342130
PMCPMC3906920
OpenAlexW1980405505

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.